Matrix 6000 (12 x 6mL)
Randlab |
MX IV 12

Matrix 6000 (12 x 6mL)

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description

For IV treatment of lameness associated with non-infectious synovitis and degenerative joint disease

Indications: Matrix 6000 IV Injection is a high molecular weight, high viscosity formulation of sodium hyaluronate. It is ideal for intravenous use in the treatment and prevention of lameness in horses due to non-infectious synovitis possibly associated with early equine degenerative joint disease.
Since this product originates from a microbial source, there is no potential for contamination with dermatan or chondroitin sulphate or any other glycosaminoglycan.

Active Constituents: Sodium Hyaluronate 10 mg/mL

Pack Size: 12 x 6mL Single Dose Vials

Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription
Ingredients:
Sodium Hyaluronate 10mg/mL